Garheng Kong is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 164,144 shares of XERS, which is worth approximately $346,343. The most recent transaction as insider was on Jun 05, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K
43.8% 3M change
52.45% 12M change
Total Value Held $346,343

Garheng Kong Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 23.35%
164,144 Common Stock
Mar 15 2024
BUY
Other acquisition or disposition
-
6,474 Added 5.37%
114,144 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
42,500 Added 28.3%
107,670 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 18.71%
65,170 Common Stock
Oct 05 2021
BUY
Grant, award, or other acquisition
-
50,170 Added 50.0%
50,170 Common Stock

Also insider at

LH
LABORATORY CORP OF AMERICA HOLDINGS Healthcare
VERO
Venus Concept Inc. Healthcare
SBBP
Strongbridge Biopharma plc
ALIM
ALIMERA SCIENCES INC Healthcare
GK

Garheng Kong

Director
Burlington, NC

Track Institutional and Insider Activities on XERS

Follow Xeris Biopharma Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XERS shares.

Notify only if

Insider Trading

Get notified when an Xeris Biopharma Holdings, Inc. insider buys or sells XERS shares.

Notify only if

News

Receive news related to Xeris Biopharma Holdings, Inc.

Track Activities on XERS